Thursday, July 31, 2025
No Result
View All Result
The Financial Observer
  • Home
  • Business
  • Economy
  • Stocks
  • Markets
  • Investing
  • Crypto
  • PF
  • Startups
  • Forex
  • Fintech
  • Real Estate
  • Analysis
  • Home
  • Business
  • Economy
  • Stocks
  • Markets
  • Investing
  • Crypto
  • PF
  • Startups
  • Forex
  • Fintech
  • Real Estate
  • Analysis
No Result
View All Result
The Financial Observer
No Result
View All Result
Home Business

‘Modern day snake-oil salesman’: The Liver Doc clashes with Bryan Johnson over ‘anti-ageing’ Blueprint

‘Modern day snake-oil salesman’: The Liver Doc clashes with Bryan Johnson over ‘anti-ageing’ Blueprint
Share on FacebookShare on Twitter


Bryan Johnson, an American entrepreneur, is famend for his anti-ageing programme referred to as Blueprint, which entails a plant-based food regimen, common train, and an in depth array of dietary supplements. 

Johnson claims his routine will reverse organic ageing and has led to biomarkers similar to these of an 18-year-old. Now, Dr Cyriac Abby Philips, a hepatologist from Kerala, has brazenly criticised Blueprint, drawing parallels between Johnson and notorious fraudsters like Elizabeth Holmes and Belle Gibson. 

Dr Philips, often called ‘The Liver Doc’, accuses Johnson of promoting overpriced and unverified dietary supplements. In keeping with Philips, Blueprint is a dangerous enterprise, devoid of considerable scientific backing. “It’s terrifying that folks don’t see Bryan Johnson as truly a well-evolved masculine type of fraudsters Elizabeth Holmes and Belle Gibson, promoting each costly and completely ineffective investigations and peddling probably harmful snake oil dietary supplements within the title of BLUEPRINT,” Dr Philips commented. 

In defence, Johnson insists his merchandise are reputable, stating all parts have “vitamins which have unbiased and sturdy scientific proof.” He additional claims they’re third-party examined, with publically out there certificates of study. 

“Blueprint provides further virgin olive oil, proteins, nuts, and vitamins which have unbiased and sturdy scientific proof. They’re third-party examined. The certificates of study are publically out there. They’re affordably priced,” Johnson asserted. 

Nonetheless, Dr Philips demanded scientific proof and dosage specifics, which he alleges Johnson has not supplied. 

The shortage of large-scale research on the security and interplay of drugs utilized in Blueprint raises further considerations, Dr Philips warns. He additionally flags potential unintended effects from the interplay of varied botanical extracts. 

Howdy @bryan_johnson, I’ve posted rational and logical questions relating to your BluePrint which I’ve gone by means of, and as scientific physician and a scientific researcher discovered it to be a rip-off.I do know precisely what I’m speaking about and do. I’m a Physician of Drugs. You might verify… https://t.co/T9h3jVnfOH

— TheLiverDoc (@theliverdr) March 31, 2025

Regardless of these points, Johnson contends his private well being enhancements are proof of Blueprint’s efficacy, although Dr Philips argues private anecdotes are usually not substitutes for scientific proof. 

Johnson, beforehand embroiled in disputes regarding office behaviour, has responded to Dr Philips’ critiques with questions concerning the physician’s motives, asking, “Cyriac why are you so indignant? Who harm you?” 

Nevertheless, Dr Philips stays resolute, regularly difficult Johnson to offer scientific validation for Blueprint’s claims. With out such proof, Philips suggests the programme stays speculative and probably deceptive for customers.  



Source link

Tags: anti-ageingantiageingBelle GibsonbiomarkersBlueprintbotanical extractsBryanBryan Johnsonclashesclinical evidenceconsumer safetydayDocDr Cyriac Abby PhilipsElizabeth HolmesJohnsonLiverModernpersonal healthplant-based dietsafety concernsSalesmanscientific evidencescientific validationscientific validitysnakeoilsupplementsThe Liver Doc
Previous Post

Barista FIRE at 36 with ONLY $500K by Trading “Stuff” for Substance

Next Post

Terminal 1 reopening revives Israel low-cost fare options

Related Posts

AI and agent security co Noma raises 0m
Business

AI and agent security co Noma raises $100m

July 31, 2025
Finding winning stocks getting tougher, bottom-up ideas key: Sridhar Sivaram
Business

Finding winning stocks getting tougher, bottom-up ideas key: Sridhar Sivaram

July 30, 2025
Ghislaine Maxwell holds out for immunity in exchange for testimony to Congress
Business

Ghislaine Maxwell holds out for immunity in exchange for testimony to Congress

July 30, 2025
Here’s What to Expect From AutoZone’s Next Earnings Report
Business

Here’s What to Expect From AutoZone’s Next Earnings Report

July 30, 2025
#9 – “Institutions Can’t Beat A Basic Buy and Hold Allocation” – Meb Faber Research
Business

#9 – “Institutions Can’t Beat A Basic Buy and Hold Allocation” – Meb Faber Research

July 29, 2025
ITR Filing 2025: Do I need to fill out any form if I want to opt out or opt in to new tax regime in ITR 1?
Business

ITR Filing 2025: Do I need to fill out any form if I want to opt out or opt in to new tax regime in ITR 1?

July 28, 2025
Next Post
Terminal 1 reopening revives Israel low-cost fare options

Terminal 1 reopening revives Israel low-cost fare options

Eurozone Inflation at 4-Month Low, DAX Rises as Rate Cut Bets Intensifies

Eurozone Inflation at 4-Month Low, DAX Rises as Rate Cut Bets Intensifies

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Trending
  • Comments
  • Latest
Guide to Connecting With Delta Customer Service: Quick Fast & Simple Help

Guide to Connecting With Delta Customer Service: Quick Fast & Simple Help

February 27, 2025
Buyers Beware: 7 Red Flags That Signal a Private Market Reckoning

Buyers Beware: 7 Red Flags That Signal a Private Market Reckoning

July 3, 2025
Listen to This BEFORE Buying a Rental with Tenants (Rookie Reply)

Listen to This BEFORE Buying a Rental with Tenants (Rookie Reply)

July 5, 2025
EUME: The Future of EU Metaverse Transactions & Its Market Value Ahead of Exchange Listing

EUME: The Future of EU Metaverse Transactions & Its Market Value Ahead of Exchange Listing

February 22, 2025
5 Affordable, Cash-Flowing Markets I’d Buy In This Year

5 Affordable, Cash-Flowing Markets I’d Buy In This Year

July 7, 2025
Air India Plane Crash: ‘We cannot say anything definite at this point,’ says Minister Murlidhar Mohol on AAIB’s preliminary report

Air India Plane Crash: ‘We cannot say anything definite at this point,’ says Minister Murlidhar Mohol on AAIB’s preliminary report

July 12, 2025
AI and agent security co Noma raises 0m

AI and agent security co Noma raises $100m

July 31, 2025
New SEC standard leans on CFTC and Coinbase to decide which digital assets get spot crypto ETFs

New SEC standard leans on CFTC and Coinbase to decide which digital assets get spot crypto ETFs

July 31, 2025
Fed Holds Rates Steady Amid Political Pressure

Fed Holds Rates Steady Amid Political Pressure

July 31, 2025
Why do people buy meme coins?

Why do people buy meme coins?

July 31, 2025
Pairs Index MT4 Indicator – ForexMT4Indicators.com

Pairs Index MT4 Indicator – ForexMT4Indicators.com

July 31, 2025
BOJ governor Ueda: Policy decision would not depend solely on new inflation forecasts

BOJ governor Ueda: Policy decision would not depend solely on new inflation forecasts

July 31, 2025
The Financial Observer

Get the latest financial news, expert analysis, and in-depth reports from The Financial Observer. Stay ahead in the world of finance with up-to-date trends, market insights, and more.

Categories

  • Business
  • Cryptocurrency
  • Economy
  • Fintech
  • Forex
  • Investing
  • Market Analysis
  • Markets
  • Personal Finance
  • Real Estate
  • Startups
  • Stock Market
  • Uncategorized

Latest Posts

  • AI and agent security co Noma raises $100m
  • New SEC standard leans on CFTC and Coinbase to decide which digital assets get spot crypto ETFs
  • Fed Holds Rates Steady Amid Political Pressure
  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2025 The Financial Observer.
The Financial Observer is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Business
  • Economy
  • Stocks
  • Markets
  • Investing
  • Crypto
  • PF
  • Startups
  • Forex
  • Fintech
  • Real Estate
  • Analysis

Copyright © 2025 The Financial Observer.
The Financial Observer is not responsible for the content of external sites.